查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464692

病毒载体和质粒 DNA 製造市场，按载体类型、工作流程、疾病、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Viral Vector and Plasmid DNA Manufacturing Market, By Vector Type, By Workflow, By Disease, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年病毒载体及质粒DNA製造市场规模为56.7398亿美元，2024年至2032年复合年增长率为19.61%。

病毒载体与质粒 DNA 製造市场-市场动态

基因治疗的进步推动市场需求

市场的主要驱动力包括基因疗法的进步，因为新基因疗法的开发在很大程度上依赖高品质的病毒载体和质粒DNA。此外，製造流程的改进使得病毒载体和质粒 DNA 的大规模生产变得更加高效，从而降低了成本并提高了整体品质。随着细胞和基因治疗研究领域的投资增加，市场对病毒载体的需求庞大。因此，各种组织正在提供资金来加速病毒载体製造流程的开发。例如，2019年9月，加拿大新一代製造公司向iVexSol Canada主导的财团拨款189万美元，用于开发慢病毒载体的先进製造流程。 iVexSol Canada 是一家向量製造公司，已与多家实体合作开发先进的 LVV 製造平台。

病毒载体和质粒 DNA 製造市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 19.81% 左右的复合年增长率成长

基于向量类型细分，预计腺相关病毒将在 2023 年显示最大的市场份额

基于工作流程细分，下游加工为2023年主导类型

根据疾病细分，2023年癌症为主导类型

基于终端用户细分，2023年研究院为主导类型

根据应用细分，反义和RNAi疗法是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

病毒载体和质粒 DNA 製造市场区隔分析：

全球病毒载体和质粒 DNA 製造市场根据载体类型、工作流程、疾病、应用、最终用户和地区进行细分。

根据载体类型，市场分为六类：腺病毒、逆转录病毒、腺相关病毒（AAV）、慢病毒、质粒和其他。就载体类型而言，腺相关病毒(AAV) 细分市场在2023 年以最大的收入份额引领市场。的利用率迅速增加出于兴趣。这种日益增长的采用归因于与骨科和眼科基因疗法开发相关的临床试验，证明了效率和功效的提高。 2022 年 8 月在 Springer 上发表的一篇文章指出，AAV 介导的基因疗法可以预防获得性听力损失，进一步强调了 AAV 在各个治疗领域的不断扩大的应用。

根据工作流程，市场分为两类：上游製造和下游製造。根据工作流程，由于临床级最终产品的抛光和纯化过程高度复杂，下游加工领域在 2023 年占据市场主导地位，收入份额最大。随着对临床级病毒载体的需求不断增长，製造商积极致力于开发新颖、经济高效的下游工艺，以应对与传统实验室规模载体製造相关的挑战。这种方法预计将支持市场成长，例如将补料分批发酵技术和基因优化的细胞系统与传统和新颖的纯化技术相结合。

病毒载体和质粒 DNA 製造市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

病毒载体与质粒 DNA 製造市场-竞争格局：

在病毒载体和质粒 DNA 製造市场的动态格局中，公司实施多样化的策略来保持竞争力并满足生物製药行业不断变化的需求。协作和策略伙伴关係在推动创新、扩展能力以及获取互补的专业知识和资源方面发挥着至关重要的作用。公司经常与生物製药公司、学术机构以及合约开发和製造组织 (CDMO) 建立策略联盟，共同开发基因治疗产品、交流研究见解并利用製造基础设施。此外，研发 (R&D) 投资对于推进製造技术、提高流程效率以及提高产品品质和可扩展性至关重要。上下游加工技术、纯化方法和分析技术的持续创新对于优化病毒载体和质粒DNA生产流程至关重要。此外，确保法规遵循和遵守良好生产规范 (GMP) 标准对于在整个製造生命週期中维持产品品质、安全性和有效性至关重要。

最近的发展：

2023 年 10 月，AGC Biologics 公布了扩建位于德国的质粒 DNA (pDNA) 製造工厂的计画。这项策略性倡议预计将使公司能够缩短製造时间。

目录

第一章：病毒载体和质粒 DNA 製造市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按载体类型分類的病毒载体和质粒 DNA 製造市场片段
    • 按工作流程分類的病毒载体和质粒 DNA 製造市场片段
    • 按疾病分類的病毒载体和质粒 DNA 製造市场片段
    • 按应用分類的病毒载体和质粒 DNA 製造市场片段
    • 最终用户的病毒载体和质粒 DNA 製造市场片段
    • 按国家/地区分類的病毒载体和质粒 DNA 製造市场片段
    • 按地区分類的病毒载体和质粒 DNA 製造市场片段
  • 竞争洞察

第 3 章：病毒载体和质粒 DNA 製造主要市场趋势

  • 病毒载体和质粒 DNA 製造市场驱动因素
    • 市场驱动因素的影响分析
  • 病毒载体和质粒 DNA 製造市场限制
    • 市场限制影响分析
  • 病毒载体和质粒 DNA 製造市场机会
  • 病毒载体与质粒 DNA 製造市场未来趋势

第 4 章：病毒载体与质粒 DNA 製造业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：病毒载体与质粒 DNA 製造市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：病毒载体与质粒 DNA 製造市场格局

  • 2023 年病毒载体和质粒 DNA 製造市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：病毒载体和质粒 DNA 製造市场 - 按载体类型

  • 概述
    • 按向量类型分類的细分市场占有率分析
    • 腺病毒
    • 逆转录病毒
    • 腺相关病毒 (AAV)
    • 慢病毒
    • 质粒
    • 其他的

第 8 章：病毒载体和质粒 DNA 製造市场 - 按工作流程

  • 概述
    • 按工作流程分類的细分市场占有率分析
    • 上游製造
    • 下游製造

第 9 章：病毒载体和质粒 DNA 製造市场 - 按疾病分类

  • 概述
    • 按疾病分類的细分市场占有率分析
    • 癌症
    • 遗传性疾病
    • 传染性疾病
    • 其他的

第 10 章：病毒载体和质粒 DNA 製造市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 反义和 RNAi 治疗
    • 基因治疗
    • 细胞疗法
    • 疫苗学
    • 研究应用

第 11 章：病毒载体和质粒 DNA 製造市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物製药公司
    • 研究机构

第 12 章：病毒载体和质粒 DNA 製造市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美病毒载体和质粒 DNA 製造主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按向量类型）
    • 北美市场规模和预测（按工作流程）
    • 北美市场规模与预测（按疾病）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲病毒载体和质粒 DNA 製造主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按向量类型）
    • 欧洲市场规模和预测（按工作流程）
    • 欧洲市场规模与预测（按疾病）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区病毒载体和质粒 DNA 製造主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按向量类型）
    • 亚太地区市场规模和预测（按工作流程）
    • 亚太地区市场规模与预测（按疾病）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲病毒载体和质粒 DNA 製造主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按向量类型）
    • 拉丁美洲市场规模和预测（按工作流程）
    • 拉丁美洲市场规模与预测（按疾病）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲病毒载体和质粒 DNA 製造主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按向量类型）
    • 中东和非洲市场规模及预测（按工作流程）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 病毒载体和质粒 DNA 製造业

  • 竞争仪表板
  • 公司简介
    • Merck KGaA
    • Lonza
    • FUJIFILM Diosynth Biotechnologies
    • Thermo Fisher Scientific
    • Cobra Biologics
    • Catalent Inc.
    • Wuxi Biologics
    • Takara Bio Inc.
    • Waisman Biomanufacturing
    • Genezen laboratories
    • Batavia Biosciences
    • Miltenyi Biotec GmbH
    • SIRION Biotech GmbH
    • Virovek Incorporation
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2452

REPORT HIGHLIGHT

Viral Vector and Plasmid DNA Manufacturing Market size was valued at USD 5,673.98 Million in 2023, expanding at a CAGR of 19.61% from 2024 to 2032.

The Viral Vector and Plasmid DNA Manufacturing sector represents a vital segment within the biopharmaceutical industry, dedicated to producing viral vectors and plasmid DNA for gene therapy and vaccine development purposes. Viral vectors are genetically engineered viruses used to transport therapeutic genes into target cells, while plasmid DNA serves as a critical component in gene therapy and DNA vaccine production. This market significantly contributes to advancing medical treatments by facilitating the development of innovative therapies for a broad spectrum of genetic disorders, infectious diseases, and cancers. Given the rapid progress in biotechnology and the increasing investment in gene therapy research, the demand for viral vectors and plasmid DNA manufacturing continues to steadily rise. This growth is fueled by factors such as the increasing prevalence of genetic diseases, the expanding pipeline of gene therapy candidates, and the growing adoption of personalized medicine approaches.

Viral Vector and Plasmid DNA Manufacturing Market- Market Dynamics

Advancements in gene therapy to propel market demand

The primary drivers of the market include advancements in gene therapy, as the development of new gene therapies heavily relies on high-quality viral vectors and plasmid DNA. Moreover, enhancements in manufacturing processes have enabled more efficient production of viral vectors and plasmid DNA at larger scales, leading to cost reductions and improved overall quality. With increased investments in the cell and gene therapy research space, there is significant demand for viral vectors in the market. Consequently, various organizations are providing funds to accelerate developments in manufacturing processes for viral vectors. For instance, in September 2019, Next Generation Manufacturing Canada granted USD 1.89 million to a consortium led by iVexSol Canada for the development of an advanced manufacturing process for lentiviral vectors. iVexSol Canada, a vector manufacturing company, has collaborated with several entities to develop an advanced LVV manufacturing platform.

Viral Vector and Plasmid DNA Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.81% over the forecast period (2024-2032)

Based on Vector Type segmentation, adeno-associated virus was predicted to show maximum market share in the year 2023

Based on Workflow segmentation, downstream processing was the leading type in 2023

Based on Disease segmentation, Cancer was the leading type in 2023

Based on end user segmentation, research institute was the leading type in 2023

Based on Application segmentation, Antisense & RNAi Therapy was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Viral Vector and Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Viral Vector and Plasmid DNA Manufacturing Market is segmented on the basis of Vector Type, Workflow, Disease, Application, End User and Region.

The market is divided into six categories based on vector type: Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids and Others. In terms of vector type, the adeno-associated virus (AAV) segment led the market with the largest revenue share in 2023. AAVs are in high demand, with their utilization in clinical trials increasing rapidly due to their precision in delivering genes to the region of interest. This rising adoption is attributed to clinical trials related to the development of orthopedic and ocular gene therapies demonstrating increased efficiency and efficacy. An article published in Springer in August 2022 stated that AAV-mediated gene therapy could prevent acquired hearing loss, further highlighting the expanding applications of AAV across various therapeutic areas.

The market is divided into two categories based on Workflow: Upstream Manufacturing and Downstream Manufacturing. Based on the workflow, the downstream processing segment dominated the market in 2023 with the largest revenue share, owing to highly complex procedures involved in polishing and purifying clinical-grade final products. With the growing demand for clinical-grade viral vectors, manufacturers are actively engaged in developing novel, cost-effective downstream processes to address challenges associated with conventional lab-scale vector manufacturing. This approach is expected to support market growth, as seen in examples such as combining fed-batch fermentation techniques and genetically optimized cell systems with conventional and novel purification technologies.

Viral Vector and Plasmid DNA Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Viral Vector and Plasmid DNA Manufacturing Market- Competitive Landscape:

In the dynamic landscape of the Viral Vector and Plasmid DNA Manufacturing market, companies implement diverse strategies to uphold competitiveness and address the evolving demands of the biopharmaceutical industry. Collaboration and strategic partnerships play a crucial role in driving innovation, expanding capabilities, and accessing complementary expertise and resources. Companies frequently establish strategic alliances with biopharmaceutical firms, academic institutions, and contract development and manufacturing organizations (CDMOs) to co-develop gene therapy products, exchange research insights, and utilize manufacturing infrastructure. Moreover, investments in research and development (R&D) are essential for advancing manufacturing technologies, enhancing process efficiency, and improving product quality and scalability. Continuous innovation in upstream and downstream processing techniques, purification methods, and analytical technologies is vital for optimizing viral vector and plasmid DNA production processes. Additionally, ensuring regulatory compliance and adhering to Good Manufacturing Practices (GMP) standards are imperative for maintaining product quality, safety, and efficacy throughout the manufacturing lifecycle.

Recent Developments:

In October 2023, AGC Biologics revealed plans for the expansion of their plasmid DNA (pDNA) manufacturing facility located in Germany. This strategic move is anticipated to enable the company to decrease manufacturing time.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck KGaA

Lonza

FUJIFILM Diosynth Biotechnologies

Thermo Fisher Scientific

Cobra Biologics

Catalent Inc.

Wuxi Biologics

Takara Bio Inc.

Waisman Biomanufacturing

Genezen laboratories

Batavia Biosciences

Miltenyi Biotec GmbH

SIRION Biotech GmbH

Virovek Incorporation

Others

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY VECTOR TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adenovirus
  • Retrovirus
  • Adeno-Associated Virus (AAV)
  • Lentivirus
  • Plasmids
  • Others

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

  • Upstream Manufacturing
  • Downstream Manufacturing

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Antisense & RNAi Therapy
  • Gene Therapy
  • Cell Therapy
  • Vaccinology
  • Research Applications

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biopharmaceutical Companies
  • Research Institutes

GLOBAL VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Viral Vector and Plasmid DNA Manufacturing Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Vector Type
    • 2.1.2.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Workflow
    • 2.1.3.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Disease
    • 2.1.4.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Application
    • 2.1.5.Viral Vector and Plasmid DNA Manufacturing Market Snippet by End User
    • 2.1.6.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Country
    • 2.1.7.Viral Vector and Plasmid DNA Manufacturing Market Snippet by Region
  • 2.2.Competitive Insights

3.Viral Vector and Plasmid DNA Manufacturing Key Market Trends

  • 3.1.Viral Vector and Plasmid DNA Manufacturing Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Viral Vector and Plasmid DNA Manufacturing Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Viral Vector and Plasmid DNA Manufacturing Market Opportunities
  • 3.4.Viral Vector and Plasmid DNA Manufacturing Market Future Trends

4.Viral Vector and Plasmid DNA Manufacturing Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Viral Vector and Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Viral Vector and Plasmid DNA Manufacturing Market Landscape

  • 6.1.Viral Vector and Plasmid DNA Manufacturing Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Viral Vector and Plasmid DNA Manufacturing Market - By Vector Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Vector Type, 2023 & 2032 (%)
    • 7.1.2.Adenovirus
    • 7.1.3.Retrovirus
    • 7.1.4.Adeno-Associated Virus (AAV)
    • 7.1.5.Lentivirus
    • 7.1.6.Plasmids
    • 7.1.7.Others

8.Viral Vector and Plasmid DNA Manufacturing Market - By Workflow

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Workflow, 2023 & 2032 (%)
    • 8.1.2.Upstream Manufacturing
    • 8.1.3.Downstream Manufacturing

9.Viral Vector and Plasmid DNA Manufacturing Market - By Disease

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Genetic Disorders
    • 9.1.4.Infectious Diseases
    • 9.1.5.Others

10.Viral Vector and Plasmid DNA Manufacturing Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Antisense & RNAi Therapy
    • 10.1.3.Gene Therapy
    • 10.1.4.Cell Therapy
    • 10.1.5.Vaccinology
    • 10.1.6.Research Applications

11.Viral Vector and Plasmid DNA Manufacturing Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Pharmaceutical and Biopharmaceutical Companies
    • 11.1.3.Research Institutes

12.Viral Vector and Plasmid DNA Manufacturing Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.Viral Vector and Plasmid DNA Manufacturing Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.Viral Vector and Plasmid DNA Manufacturing Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.Viral Vector and Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.Viral Vector and Plasmid DNA Manufacturing Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.Viral Vector and Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Viral Vector and Plasmid DNA Manufacturing Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Merck KGaA
    • 13.2.2.Lonza
    • 13.2.3.FUJIFILM Diosynth Biotechnologies
    • 13.2.4.Thermo Fisher Scientific
    • 13.2.5.Cobra Biologics
    • 13.2.6.Catalent Inc.
    • 13.2.7.Wuxi Biologics
    • 13.2.8.Takara Bio Inc.
    • 13.2.9.Waisman Biomanufacturing
    • 13.2.10.Genezen laboratories
    • 13.2.11.Batavia Biosciences
    • 13.2.12.Miltenyi Biotec GmbH
    • 13.2.13.SIRION Biotech GmbH
    • 13.2.14.Virovek Incorporation
    • 13.2.15.Others

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Methodology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: Vector Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vector Type
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type 2019-2032 (USD Million)
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: Workflow Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Workflow
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by Workflow 2019-2032 (USD Million)
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by Disease 2019-2032 (USD Million)
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by Application 2019-2032 (USD Million)
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by End User 2019-2032 (USD Million)
  • TABLE Viral Vector and Plasmid DNA Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Viral Vector and Plasmid DNA Manufacturing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by Workflow, 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Viral Vector and Plasmid DNA Manufacturing Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector and Plasmid DNA Manufacturing Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector and Plasmid DNA Manufacturing Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by Workflow, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector and Plasmid DNA Manufacturing Market, by End User, 2019-2032 (USD Million)